Pierre S. Rohrlich
0000-0001-8801-4164
4 papers found
Refreshing results…
Reduced-toxicity myeloablative conditioning regimen using fludarabine and full doses of intravenous busulfan in pediatric patients not eligible for standard myeloablative conditioning regimens: Results of a multicenter prospective phase 2 trial
Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin’s lymphoma undergoing allogeneic haematopoietic cell transplantation—a study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy
Missing publications? Search for publications with a matching author name.